• Title/Summary/Keyword: Circulating

Search Result 1,825, Processing Time 0.026 seconds

Circulating miR-221 and miR-222 as Potential Biomarkers for Screening of Breast Cancer

  • Kim, Jungho;Oh, Sehee;Park, Sunyoung;Ahn, Sungwoo;Choi, Yeonim;Kim, Geehyuk;Kim, Seung Il;Lee, Hyeyoung
    • Biomedical Science Letters
    • /
    • v.25 no.2
    • /
    • pp.185-189
    • /
    • 2019
  • Breast cancer is the second most common cancer in women with approximately 522,000 deaths annually worldwide. microRNAs have recently been studied as potential biomarkers that regulate gene expression and are involved in tumorigenesis. Here we evaluated circulating miR-221 and miR-222 as potential biomarkers for breast cancer by quantitative reverse transcription PCR using blood plasma of 30 healthy controls and 30 breast cancer patients. The TNM stage on circulating miR-221 and miR-222 was also investigated. Circulating miR-221 and miR-222 were significantly up-regulated in breast cancer patients compared to those in healthy controls (P < 0.0022 and P = 0.0058, respectively). Furthermore, the relative expression level of circulating miR-221 in patients with stage III breast cancer was higher than in those with stage I and II. Taken together, we have shown circulating miR-221 and miR-222 could be useful biomarkers for the screening of breast cancer patients.

Circulating Cell-free Tumor Nucleic Acids in Gastric Cancer (위암에서의 순환종양핵산)

  • Lee, Hyun-Ji;Lee, Sun Min
    • The Korean journal of helicobacter and upper gastrointestinal research
    • /
    • v.18 no.3
    • /
    • pp.168-173
    • /
    • 2018
  • Gastric cancer is still the leading cause of cancer deaths, especially in Asian countries. Recently, many studies have analyzed cell-free nucleic acids (cfNAs) circulating in the blood, for the early diagnosis of cancer and monitoring its progression. Circulating tumor nucleic acids (ctNAs) originate in a tumor and contain tumor-related genetic or epigenetic alterations. This review defines the nomenclatures of each form of cfNAs and describes the characteristics of circulating tumor DNA (ctDNA) and microRNA (miRNA), two major forms of ctNAs studied in gastric cancer research to date. We compare available studies on ctDNA, and explain trends observed in studies of miRNAs in gastric cancers. As these new blood-based biomarkers have attracted increasing attention, we have discussed several important points to be considered before the clinical translation of ctNA detection. We have also discussed the current status of research in this field, and clinical applications of specific ctNAs as tumor markers for gastric cancer diagnosis.

Circulating Tumor Marker (순환 종양 표지자)

  • Sung Yong Han;Dong Uk Kim
    • Journal of Digestive Cancer Research
    • /
    • v.6 no.2
    • /
    • pp.59-63
    • /
    • 2018
  • Over the past decade, circulating tumor cell have received tremendous attention as new biomarkers and basic research subjects.In recent years, research on circulating tumor DNA, exosomes and microRNAs has also been actively conducted.These circulating tumor markers have the potential to become the basis of precision medicine, such as determining the genome / immune profile, monitoring response and tolerance, and selecting therapeutic agents beyond the early diagnosis and prognosis prediction.In this article, we introduce the diagnostic methods, efficacy, meaning, and applicability of various circulating tumor markers.

  • PDF

Effects of hypoxia on the concentration of circulating miR-210 in serum and the expression of HIF-1α and HSP90α in tissues of olive flounder (Paralichthys olivaceus)

  • Abdellaoui, Najib;Kwak, Jun Soung;Kim, Ki Hong
    • Journal of fish pathology
    • /
    • v.33 no.1
    • /
    • pp.35-43
    • /
    • 2020
  • Hypoxia is a serious problem in the marine ecosystem causing a decline in aquatic resources. MicroRNAs (miRNAs) regulate the expression of genes through binding to the corresponding sequences of their target mRNAs. Especially, miRNAs in the cytoplasm can be secreted into body fluids, which called circulating miRNAs, and the availability of circulating miRNAs as biomarkers for hypoxia has been demonstrated in mammals. However, there has been no report on the hypoxia-mediated changes in the circulating miRNAs in fish. miR-210 is known as the representative hypoxia-responsive circulating miRNA in mammals. To know whether fish miR-210 also respond to hypoxia, we analyzed the change of circulating miR-210 quantity in the serum of olive flounder (Paralichthys olivaceus) in response to hypoxia. The expression of hypoxia related genes, hypoxia inducible factor 1α (HIF-1α) and the heat shock protein 90α (HSP90α) was also analyzed. Similar to the reports from mammals, miR-210-5p and miR-210-3p were significantly increased in the serum of olive flounder in response to hypoxia, suggesting that circulating miR-210 levels in the serum can be used as a noninvasive prognostic biomarker for fish suffered hypoxia. The target genes of miR-210 were related to various biological processes, which explains the major regulatory role of miR-210 in response to hypoxia. The expression of HIF-1α and HSP90α in the tissues was also up-regulated by hypoxia. Considering the critical role of HIF-1α in miR-210 expression and HSP90 in miRNAs function, the present up-regulation of HIF-1α and HSP90α might be related to the increase of circulatory miR-210, and the interaction mechanism among HIF-1α, HSP90α, and hypoxia-responsive microRNAs in fish should be further studied.

Vitamin D Sufficiency: How Should it be Defined and what are its Functional Indicators?

  • Hollis Broce W.
    • Nutritional Sciences
    • /
    • v.8 no.2
    • /
    • pp.111-117
    • /
    • 2005
  • It has been more than three decades since the first assay assessing circulating 25 (OH)D in human subjects was performed That publication as well as several that followed it defined 'normal' nutritional vitamin D status in human populations. Recently, the wisdom by which 'normal' circulating 25 (OH)D levels in human subjects were assigned in the past has come under question. It appears that sampling human subjects, who appear to be free from disease, and assessing 'normal' circulating 25 (OH)D levels by plotting a Gaussian distribution is grossly inaccurate. There are many reasons why this method is inaccurate, including race, lifestyle habits, sunscreen usage, age, latitude, and inappropriately low dietary recommendations for vitamin D. For instance, a 400 IU/day. AI for vitamin D is insignificant when one considers that a 10-15 minute whole body exposure to peak summer sun will generate and release up to 20,000 IU vitamin $D_3$ into the circulation. Recent studies, which orally administered up to 10,000 IU/day vitamin $D_3$ to human subjects for several months, have successfully elevated circulating 25 (OH)D levels to those observed in individuals from sun-rich environments. Further, we are now able to accurately assess sufficient circulating 25 (OH)D levels utilizing specific biomarkers instead of guessing what an adequate level is. These biomarkers include intact parathyroid hormone (PTH), calcium absorption, bone mineral density (BMD), insulin resistance and pancreatic beta cell function. Using the data from these biomarkers, vitamin D deficiency should be defined as circulating levels of 25 (OH)D$\leq$30 ng/mL. In certain cases, such as pregnancy and lactation, significantly higher circulating 25 (OH)D levels would almost certainly be beneficial to both the mother and recipient fetus/infant.

Vitamin D Sufficiency: How should it be defined and what are its functional indicators?

  • Hollis Bruce W.
    • Proceedings of the Korean Nutrition Society Conference
    • /
    • 2004.11a
    • /
    • pp.22-33
    • /
    • 2004
  • It has been more than three decades since the first assay assessing circulating 25(OH)D in human subjects was performed. That publication as well as several that followed it defined 'normal' nutritional vitamin D status in human populations. Recently, the wisdom by which 'normal' circulating 25(OH)D levels in human subjects were assigned in the past has come under question. It appears that sampling human subjects, who appear to be free from disease, and assessing 'normal' circulating 25(OH)D levels by plotting a Gaussian distribution is grossly inaccurate. There are many reasons why this method is inaccurate, including race, lifestyle habits, sunscreen usage, age, latitude, and inappropriately low dietary recommendations for vitamin D. For instance, a 400IU/day. AI for vitamin D is insignificant when one considers that a 10-15 minute whole body exposure to peak summer sun will generate and release up to 20,000 IU vitamin $D_3$ into the circulation. Recent studies, which orally administered up to 10,000 IU/day vitamin $D_3$ to human subjects for several months, have successfully elevated circulating 25(OH)D levels to those observed in individuals from sun-rich environments. Further, we are now able to accurately assess sufficient circulating 25(OH)D levels utilizing specific biomarkers instead of guessing what an adequate level is. These biomarkers include intact parathyroid hormone (PTH), calcium absorption, bone mineral density (BMD), insulin resistance and pancreatic beta cell function. Using the data from these biomarkers, vitamin D deficiency should be defined as circulating levels of $25(OH)D{\leq}30ng/mL$. In certain cases, such as pregnancy and lactation, significantly higher circulating 25(OH)D levels would almost certainly be beneficial to both the mother and recipient fetus/infant.

  • PDF

Circulating Current Control in MMC-HVDC Considering Switching Device Current Capacity under Unbalanced Voltage Conditions (전압 불평형 조건에서 스위칭 소자의 전류용량을 고려한 MMC-HVDC 순환전류 제어기법)

  • Kim, Chun-Sung;Jung, Seung-Hwan;Hwang, Jung-Goo;Park, Seong-Mi;Park, Sung-Jun
    • Journal of the Korean Institute of Illuminating and Electrical Installation Engineers
    • /
    • v.30 no.1
    • /
    • pp.55-65
    • /
    • 2016
  • This paper proposed a new control method which is capable of controlling circulating current considering current capacity of switching device. In the unbalanced voltage conditions, active power and reactive power have double line frequency. Thus, in order to provide active power without ripple, it is necessary to inject the negative sequence current components. However, when the negative current components is injected, it increases the total current flowing in the Arm, and in the Sub-module(SM) the current more than rated is impressed, which leads to destroy the system. Also, in impressing the circulating current reference of each arm, conventional control method impressed applicable $i_{dck}/3$ in the case of balanced voltage conditions. In the case of unbalanced conditions, as arm circulating current of three phase show difference due to the power impressed to each arm, reference of each arm is not identical. In this study, in the case of unbalanced voltage, within permitted current, the control method to decrease the ripple of active power is proposed, through circulating current control and current limitations. This control method has the advantage that calculates the maximum active power possible to generate capacity and impressed the current reference for that much. Also, in impressing circulating current reference, a new control method proposes to impress the reference from calculating active power of each phase. The proposed control method is verified through the simulation results, using the PSCAD/EMTDC.

Evaluation of circulating PD-1 and PD-L1 as diagnostic biomarkers in dogs with tumors

  • Song, Doo-Won;Ro, Woong-Bin;Park, Hee-Myung
    • Journal of Veterinary Science
    • /
    • v.22 no.5
    • /
    • pp.75.1-75.10
    • /
    • 2021
  • Background: Programmed cell death protein-1 (PD-1) and programmed cell death ligand-1 (PD-L1) have important roles in tumor evasion of the immune system. Objectives: This study aimed to assess the diagnostic utility of circulating PD-1 and PD-L1 levels in healthy dogs and dogs with tumors. Methods: Circulating PD-1 and PD-L1 levels in the serum of 71 dogs with tumors were compared with those of 52 healthy dogs by performing enzyme-linked immunosorbent assay (ELISA). Results: The ELISA results revealed higher circulating PD-1 and PD-L1 levels in dogs with tumors (2.9 [2.2-3.7] ng/mL; median [IQR] and 2.4 [1.4-4.4] ng/mL, respectively) than in healthy dogs (2.4 [1.9-3.0] ng/mL; p = 0.012 and 1.4 [0.9-2.1] ng/mL; p < 0.001, respectively). Especially, there was a significant difference in circulating PD-1 levels between healthy dogs and dogs with malignant epithelial tumors (2.4 [1.9-3.0] ng/mL and 3.1 [2.6-4.4] ng/mL, respectively; p < 0.01). In addition, there was a significant difference in circulating PD-L1 levels between healthy dogs and dogs with lymphomas (1.4 [0.9-2.1] ng/mL and 2.7 [1.6-5.8] ng/mL, respectively; p < 0.001). Conclusion: This study indicates that circulating PD-1 and PD-L1 have potential as tumor diagnostic biomarkers in dogs with tumors.

Control of HVDC-MMC Considering the Switching Device's Current Capacity and Circulating Current under Unbalanced Voltage Conditions (불평형 전압 조건에서 스위칭 소자의 전류 용량과 순환전류를 고려한 HVDC-MMC 제어기법)

  • Moon, Ji-Woo;Pae, Deuk-Woo;Park, Jung-Woo;Kang, Dea-Wook;Yoo, Dong-Wook;Kim, Jang-Mok
    • The Transactions of the Korean Institute of Power Electronics
    • /
    • v.18 no.3
    • /
    • pp.270-278
    • /
    • 2013
  • This paper proposes a control method for high voltage direct current(HVDC) with modular multilevel converter (MMC) under unbalanced voltage conditions considering the submodule(SM)'s current capacity and circulating current. It is aimed to propose a control method in which the current peak value does not exceed the maximum value of HVDC-MMC by considering the current capacity of the SM under unbalance voltage conditions. And it analyzes the effect of the unbalanced voltage on circulating currents in MMC and then proposes a control method considering each component of circulating currents under unbalanced voltages. The effectiveness of the proposed controlling method is verified through simulation results using PSCAD/EMTDC.

POSCA: A computer code for fission product plateout and circulating coolant activities within the primary circuit of a high temperature gas-cooled reactor

  • Tak, Nam-il;Lee, Jeong-Hun;Lee, Sung Nam;Jo, Chang Keun
    • Nuclear Engineering and Technology
    • /
    • v.52 no.9
    • /
    • pp.1974-1982
    • /
    • 2020
  • Numerical prediction of fission product plateout and circulating coolant activities under normal operating conditions is crucial in the design of a high temperature gas-cooled reactor (HTGR). The results are used for the maintenance and repair of the components as well as the safety analysis regarding early source terms under loss of coolant accident scenarios. In this work, a new computer code named POSCA (Plate-Out Surface and Circulating Activities) was developed based on a one-dimensional model to evaluate fission product plateout and circulating coolant activities within the primary circuit of a HTGR. The verification and validation of study for the POSCA code was done using available analytical results and two in-pile experiments (i.e., OGL-1 and VAMPYR-1). The results of the POSCA calculations show that POSCA is able to simulate plateout and circulating coolant activities in a HTGR with fast computation and reasonable accuracy.